National Institutes of Pharmaceutical Research and Development (China)
- World rank, all time
- #28,516 of 42,892
- Rank in China
- #2,748 of 3,536
- Research works
- 272 ▲ 37% vs 2013–17
- Citations
- 3.7k 13.6 per fractional work
- Top-10% rate
- 22.4% record average 16.5%
- Open access
- 24% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 9.7×
- Biochemistry, Genetics and Molecular Biology 5.6×
- Immunology and Microbiology 4.7×
- Chemistry 3.1×
- Veterinary 2.2×
- Medicine 1.9×
- Neuroscience 1.8×
- Materials Science 1.1×
- Energy 0.8×
- Decision Sciences 0.8×
- Agricultural and Biological Sciences 0.7×
- Nursing 0.4×
- Environmental Science 0.4×
- Economics, Econometrics and Finance 0.4×
- Physics and Astronomy 0.3×
- Engineering 0.2×
- Health Professions 0.2×
- Psychology 0.1×
- Computer Science 0.1×
- Social Sciences 0.0×
Which keywords describe research at National Institutes of Pharmaceutical Research and Development (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Oxidative Stress, Antioxidant, Anti-inflammatory, Inflammation, Apoptosis, Cancer Therapy and Pharmacology.
- Mass Spectrometry
- Mitochondrial Dysfunction
- Cancer Treatment
- Natural Products
- Drug Delivery
- Saponins
- Pharmacokinetics
- Neurodegenerative Diseases
- Tumor Microenvironment
- Clinical Trials
- Traditional Chinese Medicine
- Antioxidant Activity
- Cell Death
- Anticancer
- Medicinal Plants
- Antiviral
- Pharmacology
- Apoptosis
- Antioxidant
- Oxidative Stress
- Cancer
- Inflammation
- Anti-inflammatory
- Cancer Therapy
- Biomarkers
- Biological Activities
- Reactive Oxygen Species
- Biomedical Applications
- Herbal Medicine
- Metabolism
- Antioxidants
- Triterpenoids
- Epigenetic Regulation
- Neuroprotective Effects
- Pharmacological Properties
- Diabetes
- Flavonoids
- Precision Medicine
- Metabolic Regulation
- Cancer Immunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer5▲ 7.2×18 topics
- Oxidative Stress5▲ 5.5×26 topics
- Inflammation5▲ 4.0×31 topics
- Antioxidant4▲ 10×16 topics
- Anti-inflammatory3▲ 23×8 topics
- Apoptosis3▲ 18×9 topics
- Cancer Therapy2▲ 7.6×11 topics
- Pharmacology2▲ 15×6 topics
- Biomarkers2▲ 5.0×9 topics
- Antiviral2▲ 40×2 topics
- Biological Activities2▲ 21×4 topics
- Medicinal Plants2▲ 8.4×8 topics
- Reactive Oxygen Species2▲ 8.2×7 topics
- Anticancer2▲ 20×5 topics
- Biomedical Applications2▲ 2.7×9 topics
- Cell Death2▲ 14×6 topics
- Herbal Medicine2▲ 11×5 topics
- Antioxidant Activity2▲ 4.6×9 topics
- Metabolism2▲ 5.8×11 topics
- Traditional Chinese Medicine2▲ 24×4 topics
- Antioxidants2▲ 6.0×8 topics
- Clinical Trials2▲ 4.1×9 topics
- Triterpenoids2▲ 42×2 topics
- Tumor Microenvironment2▲ 6.2×5 topics
- Epigenetic Regulation1▲ 11×4 topics
- Neurodegenerative Diseases1▲ 15×6 topics
- Neuroprotective Effects1▲ 16×6 topics
- Pharmacokinetics1▲ 9.5×6 topics
- Pharmacological Properties1▲ 30×1 topic
- Saponins1▲ 66×1 topic
- Diabetes1▲ 4.8×8 topics
- Drug Delivery1▲ 4.5×6 topics
- Flavonoids1▲ 9.3×8 topics
- Natural Products1▲ 16×3 topics
- Precision Medicine1▲ 5.3×3 topics
- Cancer Treatment1▲ 9.1×6 topics
- Metabolic Regulation1▲ 13×2 topics
- Mitochondrial Dysfunction1▲ 7.3×5 topics
- Cancer Immunotherapy1▲ 13×3 topics
- Mass Spectrometry1▲ 13×3 topics
Which research topics does National Institutes of Pharmaceutical Research and Development (China) publish most on?
By volume in 2022–2025: Natural product bioactivities and synthesis, Gut microbiota and health, Metabolomics and Mass Spectrometry Studies and Drug Transport and Resistance Mechanisms.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Natural product bioactivities and synthesis Molecular Biology 1 works
- 2 Gut microbiota and health Molecular Biology 1 works
- 3 Metabolomics and Mass Spectrometry Studies Molecular Biology 1 works
- 4 Drug Transport and Resistance Mechanisms Oncology 1 works
- 5 Mitochondrial Function and Pathology Molecular Biology 1 works
- 6 Traditional Chinese Medicine Studies Complementary and alternative medicine 1 works
- 7 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 8 Bioactive natural compounds Molecular Biology 1 works
- 9 Cancer-related molecular mechanisms research Cancer Research 1 works
- 10 Peptidase Inhibition and Analysis Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Institutes of Pharmaceutical Research and Development (China)'s research output changed?
Output in 2018–2022 was 37% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.